Check out the companies making headlines in midday trading: Tesla — Elon Musk’s electric vehicle company saw shares sliding another 5.2%, bringing month-to-date losses to around 23%. The sell-off came after Tesla’s China rival Zeekr said it is rolling out an advanced driver-assistance system for free . Meanwhile, RBC Capital Markets lowered its price target on Tesla amid lowered expectations around pricing for the company’s self-driving capabilities. Alphabet — Shares of the Google parent slid 2.7%. Google said on Tuesday that it signed a definitive agreement to acquire cloud security startup Wiz for $32 billion in an all-cash deal. This deal is slated to be Google’s largest-ever acquisition. Palantir — Shares slid 4%. Jefferies also reiterated the defense technology stock as underperform , saying valuation remains a concern. Nvidia — The chipmaker retreated 3.3% ahead of CEO Jensen Huang’s keynote speech at the company’s GTC AI Conference. Lucid — The EV stock climbed 8.8% following Morgan Stanley’s upgrade to equal weight from underweight. Morgan Stanley said Lucid has an emerging bull case tied to artificial intelligence. Sarepta Therapeutics — The biotechnology company plunged 27.4% after disclosing the death of a man who was treated with its Elevidys gene therapy. Sarepta said in a statement that acute liver injury is a known potential side effect. Eastman Kodak — Shares of the film and chemicals manufacturer fell 6.4% after the company reported mixed fourth-quarter results. Eastman Kodak posted consolidated revenue of $266 million, compared with $275 million for the fourth quarter of 2023, reflecting a 3% decrease. The company reported a jump in net income for the fourth quarter, however, generating $26 million in net income for the quarter. That is up from $5 million in the year-ago period. Peabody Energy — The coal mining company advanced 6.2% after President Donald Trump, writing on his social media platform Truth Social , said he is authorizing energy production using coal. Willis Towers Watson — The commercial insurance stock climbed 2% on the heels of UBS’ upgrade to buy from neutral. UBS said the company has seen faster improvement on operating and free cash flow margins than peers. Millrose Properties — The residential land developer popped more than 10% after the company declared a dividend and issued new guidance. Millrose will pay shareholders 38 cents per share. It added that it sees fiscal second-quarter earnings per share between 65 cents and 68 cents. Hims & Hers Health — The digital health stock tumbled 9.2% after the U.S. Food and Drug Administration shared concerns around unapproved GLP-1 drugs used for weight loss, including compounded versions. Hims & Hers began prescribing compounded semaglutide last year. — CNBC’s Brian Evans, Pia Singh, Yun Li and Fred Imbert contributed reporting.
Add A Comment
About Us
Our finance blog is your go-to resource for expert financial advice, covering everything from personal budgeting and saving strategies to smart investing and market analysis. Stay updated with the latest trends, tips, and insights to help you make informed decisions and achieve financial success.
Popular Post
© 2025 Budgetsmart.ai – All rights reserved.